How do I buy Insulet (PODD) stock?

Buying Insulet (PODD) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and verify your identity. Make a deposit. Search for the code "PODD", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy PODD by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if PODD is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Insulet (PODD) Stock

Q: What is the minimum investment for PODD on Gotrade?

On Gotrade , you don't have to buy a full share. With fractional shares, you can start investing in Insulet from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NSQ · PODD

Trade PODD

Key stats

Market cap: $10.41B
Price / Earnings ratio: 24.0x
EPS (TTM): $6.14
Volume: Loading
52-week high: $354.88
52-week low: $126.40
EPS vs analyst estimate: +8.8%Q3 FY25 · $1.24 vs $1.14

Source: third-party data provider, as of November 13, 2026

EPS estimate: analyst consensus

Compare with PODD

Technical indicators

RSI 14: 53.12
MACD 12/26/9: 2.93
EMA 9 of MACD: 3.39
MACD histogram: -0.46
SMA 50: $142.08; Price above SMA 50
EMA 50: $146.07; Price above EMA 50
SMA 200: $173.76; Price below SMA 200
EMA 200: $185.49; Price below EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Hold

Based on 10 analyst ratings

Strong Sell0

Sell0

Hold7

Buy3

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2021

2022

2023

2024

2025

3B2B1B0

Debt & Balance Sheet

Total assets

Total liabilities

2021

2022

2023

2024

2025

4B3B1B0

Revenue to Profit

2025

$2.7B

Revenue

$0.0

Cost of revenue

$1.9B

Gross profit

$0.0

Operating expenses

$247.1M

Net income

Earnings

EPS forecast

Actual EPS

$1.24

$1.14

Q3FY25

$1.47

Q4FY25

$1.20

Q1FY26

$1.45

Q2FY26

$1.70

Q3FY26

The market is expecting earnings per share of $1.70 for this quarter. The company has not yet shared when it is announcing earnings.

Source: third-party data provider

About Insulet

Insulet is an innovative medical device company. With the mission of improving the lives of people with diabetes and through our revolutionary Omnipod Insulin Management System, we seek to expand the use of insulin pump therapy.

SectorHealthcare

IndustryMedical Devices

Employees5,400

CEOMs. Ashley A. McEvoy

IPO DateMay 15, 2007

HeadquartersActon, MA

Key Executives

Name	Title	Year Born
Ms. Ashley A. McEvoy	CEO, President & Director	1971
Ms. Flavia H. Pease	Executive VP & CFO	1973
Mr. Eric Benjamin	Executive VP & COO	1983
Mr. John Wodick Kapples J.D.	Senior VP & General Counsel	1960
Mr. Prem Singh	Senior Vice President of Global Operations	1977
Mr. Amit Guliani	Senior VP & CTO	—
Ms. Clare Trachtman	Vice President of Investor Relations	—
Mr. Chuck Medovich	Senior VP and Chief Quality, Regulatory & Compliance Officer	—
Ms. Angela Geryak Wiczek	Senior Director of Corporate Communications	—
Mr. Philip Hildale	Senior Vice President of Sales & Customer Care	—

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											-8.8	-6.1
2022	-10.0	+6.7	+2.1	-14.3	-13.6	+5.1	+9.4	+4.0	-11.6	+11.1	+12.5	-4.4
2023	+0.3	-4.9	+12.9	-0.3	-14.0	+5.8	-2.4	-29.2	-17.0	-19.7	+37.3	+12.9
2024	-8.7	-16.1	+1.3	+2.3	+4.1	+11.2	-0.9	+2.8	+12.6	-1.3	+13.2	-2.0
2025	+8.4	-2.4	-3.7	-4.1	+29.9	-3.3	-3.9	+19.3	-10.5	+2.3	+2.6	-8.6
2026	-9.6	-3.9	-14.5	-16.9	-17.2	+2.8	+3.5	-12.4	-12.1	+14.4	-2.3

Stocks in the same sector

FAQ

Buying Insulet (PODD) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and verify your identity.
Make a deposit.
Search for the code "PODD", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy PODD by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full share. With fractional shares, you can start investing in Insulet from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, Insulet (PODD) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track PODD's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too.

The market is closed on US public holidays. The Gotrade app shows whether the market is open.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

Insulet (PODD) Stock

Key stats

Compare with PODD

Recent news

Insulet to Participate in the 2026 Jefferies Global Healthcare Conference in London

Insulet to Participate in the 2026 Jefferies Global Healthcare Conference in London

Insulet (PODD) Reports Next Week: Wall Street Expects Earnings Growth

Insulet (PODD) Reports Next Week: Wall Street Expects Earnings Growth

Here's Why Insulet (PODD) is a Strong Growth Stock

Here's Why Insulet (PODD) is a Strong Growth Stock

Insulet Announces Omnipod Discover Now Available in U.S.

Insulet Announces Omnipod Discover Now Available in U.S.

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Insulet to Participate in the 2026 Jefferies Global Healthcare Conference in London

Insulet to Participate in the 2026 Jefferies Global Healthcare Conference in London

Insulet (PODD) Reports Next Week: Wall Street Expects Earnings Growth

Insulet (PODD) Reports Next Week: Wall Street Expects Earnings Growth

Here's Why Insulet (PODD) is a Strong Growth Stock

Here's Why Insulet (PODD) is a Strong Growth Stock

Insulet Announces Omnipod Discover Now Available in U.S.

Insulet Announces Omnipod Discover Now Available in U.S.

Insulet to Announce Third Quarter 2026 Financial Results on November 4, 2026

Insulet to Announce Third Quarter 2026 Financial Results on November 4, 2026

Why Insulet (PODD) is a Top Growth Stock for the Long-Term

Why Insulet (PODD) is a Top Growth Stock for the Long-Term

Insulet Targets Type 2 Retention as Omnipod 6 and Global Growth Gain Momentum

Insulet Targets Type 2 Retention as Omnipod 6 and Global Growth Gain Momentum

Insulet to Participate in Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum

Insulet to Participate in Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum

Here's Why Insulet (PODD) is a Strong Growth Stock

Here's Why Insulet (PODD) is a Strong Growth Stock

Is it Prudent to Retain Insulet Stock in Your Portfolio for Now?

Is it Prudent to Retain Insulet Stock in Your Portfolio for Now?

About Insulet

Key Executives

Fundamentals

Valuation

Profitability

Trading

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade